| Literature DB >> 32931079 |
Amresh Kumar1, Partha Palit2, Sabu Thomas3, Gaurav Gupta4,5, Parasar Ghosh6, Rudra Prosad Goswami7, Tapan Kumar Maity8, Manabendra Dutta Choudhury1.
Abstract
Osteoarthritis (OA), a disorder of joints, is prevalent in older age. The contemporary cure for OA is aimed to confer symptomatic relief, consisting of temporary pain and swelling relief. In this paper, we discuss various modalities responsible for the onset of OA and associated with its severity. Inhibition of chondrocytes receptors such as DDR2, SDF-1, Asporin, and CXCR4 by specific pharmacological inhibitors attenuates OA, a critical step for finding potential disease modifying drugs. We critically analyzed recent OA studies with an emphasis on intermediate target molecules for OA intervention. We also explored some novel and safe treatments for OA by considering disease prognosis crosstalk with cellular signaling pathways.Entities:
Keywords: CXCR4; DDR2; SDF-1; asporin; gut-microbiome; leptin; osteoarthritis
Mesh:
Substances:
Year: 2020 PMID: 32931079 DOI: 10.1002/ddr.21741
Source DB: PubMed Journal: Drug Dev Res ISSN: 0272-4391 Impact factor: 4.360